Fainting affects one in two people during their lifetime. Those with recurrent episodes are often afraid to socialize or go to work. Today researchers report the first effective therapy. The late breaking research is presented at ESC Congress 2020.
A new study examines the effects of cancer and its treatment on the ageing process. Investigators found that expression of a gene associated with ageing is higher in young patients with cancer after treatment with chemotherapy and in young cancer survivors who are frail. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society (ACS).
With more than 1.8 million new cases reported in 2018 — a 9.5 percent increase compared to 1990 — colorectal cancer is the world’s third most prevalent form of cancer: The second most common cancer type in women and the third most common for men.
A prominent Iranian lawyer criticized the illegal sanctions imposed by the United States on Iran, which have seriously affected the treatment of Iranian patients and stressed the need to punish those who have imposed the sanctions.
A novel formulation of the prostate cancer drug abiraterone acetate — currently marketed as Zytiga — will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials by the University of South Australia show the new formulation improves the drug’s effectiveness by 40 percent.
A new nonsurgical treatment decreases errant blood flow in the shoulder to quickly reduce pain and improve function in patients with adhesive capsulitis, also known as "frozen shoulder," according to a research abstract presented during a virtual session of the Society of Interventional Radiology's 2020 Annual Scientific Meeting.